checkAd

     122  0 Kommentare Clever Culture Systems Appoints Thermo Fisher Scientific as Exclusive US APAS Distributor - Seite 2

    LBT CEO and Managing Director, Brent Barnes said:

    "This is a really important milestone for LBT and represents a major step forward in our commercialisation strategy in the United States. We have spoken previously about the importance of appointing well recognised, leading distributors to support our sales efforts in key markets. Thermo Fisher is a leader in microbiology that is recognised globally, and we will benefit greatly from the depth and strength of their sales team in the United States.  Our management team have worked diligently to secure this partnership and we are really excited to begin working alongside the Thermo Fisher team. We hope that this is the beginning of a long and fruitful relationship between our two companies.

    We are very pleased to now have two of the world's largest microbiology companies selling our technology across the two main markets of the United States and Europe, which is a further validation of benefits of our technology."  

    – ENDS –

    About LBT Innovations

    LBT Innovations (LBT) improves patient outcomes by making healthcare more efficient.  Based in Adelaide, South Australia, the Company has a history of developing world leading products in microbiology automation.  Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process.  The Company's second product, the Automated Plate Assessment System (APAS) is being commercialised through LBT's 50% owned joint venture company Clever Culture Systems AG (CCS) with Hettich Holding Beteiligungs- und Verwaltungs-GmbH.  Beckman Coulter have also been appointed as Marketing Agent in Europe to assist in facilitating sales. The APAS instrument is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis and interpretation of culture plates following incubation.

    CONTACTS

    LBT Innovations

    Investor Enquiries

    Brent Barnes
    Chief Executive Officer & Managing Director
    Tel: +61 8 8227 1555
    E: info@lbtinnovations.com

    David Allen / John Granger

    Hawkesbury Partners

    Tel: +61 2 9103 9494

    E: jgranger@hawkesburypartners.com

     

    Logo - https://mma.prnewswire.com/media/1635593/LBTInnovations_Logo.jpg

    Seite 2 von 2



    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Clever Culture Systems Appoints Thermo Fisher Scientific as Exclusive US APAS Distributor - Seite 2 ADELAIDE, Australia, Sept. 27, 2021 /PRNewswire/ - Australian medical technology company LBT Innovations Limited (ASX: LBT) (LBT or the Company), a leader in medical technology automation using artificial intelligence, is pleased to announce the …

    Schreibe Deinen Kommentar

    Disclaimer